Fertility clinic due diligence

By the time you are under an LOI on a fertility clinic, the valuation and structural questions are largely behind you, and diligence turns to verification: proving that what the clinic told you about its physicians, its lab, its funding-program participation and its specimen records actually holds up on paper. Three findings in this sub-sector are serious enough to end a deal outright, and a diligence process that is built around finding them early, rather than discovering them at the closing table, is the whole point of this stage.

Verify physician retention in writing, not in conversation

Get the retention or transition agreement with every reproductive endocrinologist central to the clinic’s volume in writing, reviewed by counsel, and confirmed as executed — not described to you secondhand by the seller. A physician who orally agreed to stay and then changes their mind after closing is one of the most damaging outcomes a buyer of a fertility clinic can face, because so much of the clinic’s referral pipeline and success-rate reputation is attached to that individual specifically.

Confirm funding-program participation directly with the administrator

Where the clinic participates in a provincial fertility-funding program, contact the program administrator directly, through the seller with appropriate consent, rather than relying solely on the seller’s representation that participation will continue. Ask specifically what reapplication or confirmation process applies on a change of ownership, what the realistic timeline is, and whether any prior compliance issues exist on the clinic’s file. A funding program that cannot be maintained or re-approved under new ownership can remove a meaningful share of expected patient volume overnight.

Audit the cryopreservation chain of custody

Request a full audit of cryopreserved-specimen storage records — what is stored, under what consent, with what monitoring and alarm history on the storage tanks, and whether the chain of custody is complete for every specimen on file. A gap here is not a paperwork technicality: it points to a compliance and patient-safety exposure that is expensive and slow to remediate, and it is one of the clearest reasons a buyer walks away from an otherwise strong clinic.

Review the embryology lab’s accreditation and equipment condition

Get the lab’s current accreditation certificate, its renewal date, and a maintenance and service history for incubators, cryostorage tanks and monitoring systems, since this equipment is both clinic-specific and expensive to replace. An accreditation lapse, or equipment nearing the end of its service life without a replacement plan, is a near-term capital cost that should be reflected in the purchase price or addressed as a closing condition rather than discovered after you own the clinic.

Confirm the lease and equipment financing obligations you are assuming

Pull the current lease, confirm its remaining term and any landlord consent required to assign it, and get a complete list of any outstanding equipment financing or leases tied to the embryology lab equipment, since these obligations typically transfer with the business and change your actual cost of acquisition. A lab described as owned outright that turns out to be encumbered by an equipment lease with years remaining is a common gap between what a seller represents informally and what the paperwork actually shows.

Check for outstanding college or accreditation complaints

Request confirmation, in writing, of whether any physician at the clinic or the embryology lab itself has an open complaint, investigation or condition with the relevant college or accreditation body. An unresolved matter does not necessarily kill a deal, but it needs to be understood and priced, or made a condition of closing, rather than discovered after you have taken over a clinic with a live regulatory issue attached to it.

Reconcile revenue by funding source before you rely on the summary

Ask for cycle-level revenue broken out by physician-billed provincial insurance, private-pay treatment, provincial funding-program billing and ancillary services, rather than accepting a single blended revenue figure. This reconciliation is the fastest way to see whether the clinic’s income is as diversified as it was described, or whether it is more concentrated in a single funding source than the summary numbers suggested.

Verify data-sharing agreements with referring physicians and outside labs

A fertility clinic routinely shares patient information with referring physicians, outside genetic-testing labs and, in some cases, donor or surrogacy-matching services, and each of those relationships should be backed by a data-sharing or confidentiality agreement consistent with applicable privacy law. Ask for the current list of external parties who receive patient information in the ordinary course of the clinic’s operations, and confirm each relationship has proper documentation rather than assuming informal, longstanding referral relationships meet the same bar.

What the underlying documents should actually show

• Patient files, treatment history and cryopreserved-specimen records, with consent documentation for their transfer to a new owner
• Physician and embryologist employment or partnership agreements, including any retention or non-solicitation terms
• Provincial fertility-funding-program registration correspondence and any compliance history on file
• Assisted-human-reproduction consent and counselling documentation, confirming the clinic’s ongoing process meets its federal obligations